Description

This research service evaluates the U.S. quantitative polymerase chain reaction (qPCR) and digital PCR (dPCR) instrumentation markets from 2009 to 2016. Though related, they present distinct market scenarios, with qPCR at a mature market stage and dPCR just emerging. However, competitive expansion and pricing effects are significant topics for each. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive landscape of these markets, revenue forecasts for each technology, and the important trends affecting growth. Lastly, this analysis presents three major market predictions their implications for competitors.